Immunotechnology

Antibody-targeted superantigens in cancer immunotherapy
pp. 151-162(12)
Authors: Sogaard M.; Hansson J.; Litton M.J.; Ohlsson L.; Rosendahl A.; Lando P.A.; Antonsson P.; Kalland T.; Dohlsten M.

Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding
pp. 169-179(11)
Authors: Davies J.; Riechmann L.

Generation of a panel of related human scFv antibodies with high affinities for human CEA
pp. 181-196(16)
Authors: Osbourn J.K.; Field A.; Wilton J.; Derbyshire E.; Earnshaw J.C.; Jones P.T.; Allen D.; McCafferty J.

Improving the copy numbers of antibody fragments expressed on the major coat protein of bacteriophage M13
pp. 197-207(11)
Authors: Nakayama G.R.; Valkirs G.; McGrath D.; Huse W.D.

In vitro selection of a high affinity antibody to oestradiol using a phage display human antibody library
pp. 209-217(9)
Authors: Pope A.; Pritchard K.; Williams A.; Roberts A.; Hackett J.R.; Mandecki W.; Johnson K.S.

Cloning, expression and functional activities of a single chain antibody fragment directed to fusion protein of respiratory syncytial virus
pp. 219-228(10)
Authors: Guirakhoo F.; Catalan J.; Monath T.; Weltzin R.

Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin
pp. 229-240(12)
Authors: Gorovaya T.A.; Korotkov V.N.; Dunn R.D.; Weston K.M.; Longhurst T.J.; Lilley G.G.; Rivett D.E.; Hudson P.J.; Raison R.L.